NCT06268665
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy No drug interventions treatment 2 recruiting NCT03304210
PIPAC Nab-pac for Stomach, Pancreas, Breast and Ovarian Cancer treatment 1 completed NCT03723863
Occupational Therapist-Led Work Intervention in Facilitating Work Maintenance or Re-entry to the Workforce in Patients With Stage I to III Breast Cancer Undergoing Chemotherapy No drug interventions supportive_care Not Available terminated NCT01723943
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients No drug interventions supportive_care Not Available completed NCT01043003
Bilingual Breast Cancer Educational Intervention for Hispanic Women With Stage I, Stage II, or Stage III Breast Cancer and Their Families or Caregivers No drug interventions supportive_care Not Available completed NCT01959490
Trastuzumab and Pertuzumab or Bevacizumab With Combination Chemotherapy in Treating Patients With Stage II-III Breast Cancer basic_science 2 completed NCT02370264
Questionnaires in Identifying Upper Extremity Function and Quality of Life After Treatment in Patients With Breast Cancer No drug interventions supportive_care Not Available terminated NCT01869764
Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer treatment 2 completed NCT02046421
Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer treatment 1 completed NCT01672684
Phase I: At-Home Support for Rural Women Using Group Video Calling No drug interventions supportive_care 1 completed NCT01941784
Health Education Intervention in Reducing Weight Gain in Patients With Newly Diagnosed Stage I-IV Breast Cancer Undergoing Chemotherapy No drug interventions supportive_care Not Available completed NCT01372579
Carboplatin and Eribulin Mesylate in Triple Negative Breast Cancer Patients treatment 2 unknown_status NCT01628887
Feasibility of a Supportive Education Program for Latina Breast Cancer Survivors No drug interventions supportive_care Not Available terminated NCT01730833
Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer treatment 2 active_not_recruiting NCT01238133
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer treatment 1 terminated NCT02002533
Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy No drug interventions supportive_care Not Available completed NCT00436254
Vaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian Cancer treatment 1 active_not_recruiting NCT02060253
Ganetespib, Paclitaxel, Trastuzumab and Pertuzumab for Metastatic Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer treatment 1 completed NCT02827877
Cu64-DOTA-trastuzumab PET and Markers Predicting Response to Neoadjuvant Trastuzumab + Pertuzum in HER2+ Breast Cancer treatment 2 active_not_recruiting NCT02454777
High-Intensity Interval Training for Stage I-III Breast Cancer Patients No drug interventions supportive_care Not Available terminated NCT01233505
Veliparib, Oxaliplatin, and Capecitabine in Treating Patients With Advanced Solid Tumors treatment 1 terminated NCT01245205
Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer treatment 1 completed NCT02699983
eHealth Weight Loss Program in African American Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT01292083
Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery treatment Not Available withdrawn NCT01288261
Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer treatment 1 completed NCT01558778
Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant No drug interventions supportive_care Not Available withdrawn NCT00559507
Saracatinib in Treating Patients With Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed By Surgery treatment 2 completed NCT03971409
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer treatment 2 recruiting NCT00986609
MUC1 Vaccine for Triple-negative Breast Cancer other 0 completed NCT00343109
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Cancer prevention 2 completed NCT03566485
Atezolizumab and Cobimetinib or Idasanutlin in Participants With Stage IV or Unresectable Recurrent Estrogen Receptor Positive Breast Cancer treatment 1 / 2 terminated NCT00416715
Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer supportive_care 2 completed NCT01013337
Acupuncture in Treating Women With Stage I, Stage II, or Stage III Breast Cancer With Aromatase Inhibitor-Related Joint Pain No drug interventions supportive_care Not Available completed NCT01729832
Stereotactic Image-Guided Navigation During Breast Reconstruction in Patients With Breast Cancer No drug interventions supportive_care Not Available withdrawn NCT01632332
Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer treatment 1 completed NCT02273752
Pharmacokinetically Guided Everolimus in Patients With Breast Cancer, Pancreatic Neuroendocrine Tumors, or Kidney Cancer treatment 2 terminated NCT02860000
Alisertib With or Without Fulvestrant in Treating Patients With Locally Advanced or Metastatic, Endocrine-Resistant Breast Cancer treatment 2 active_not_recruiting NCT02015559
Mucoadhesive Oral Wound Rinse in Preventing and Treating Stomatitis in Patients With ER- or PR-Positive Metastatic or Locally Recurrent Breast Cancer That Cannot be Removed by Surgery Receiving Everolimus No drug interventions supportive_care 2 completed NCT01050075
Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel No drug interventions supportive_care Not Available terminated NCT01806675
18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy diagnostic 1 / 2 completed NCT00368875
Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer treatment 1 / 2 completed NCT02897375
Palbociclib With Cisplatin or Carboplatin in Advanced Solid Tumors treatment 1 completed NCT03091842
Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer No drug interventions supportive_care Not Available withdrawn NCT01824836
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) supportive_care Not Available active_not_recruiting NCT00080613
Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer treatment 2 withdrawn NCT01754519
Radiation Therapy in Treating Post-Menopausal Women With Early Stage Breast Cancer Undergoing Surgery No drug interventions treatment 2 terminated NCT03128619
Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer treatment 1 terminated NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT01606241
Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer treatment 1 completed NCT01897441
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer treatment Not Available active_not_recruiting NCT00063934
Oblimersen Plus Doxorubicin and Docetaxel in Treating Patients With Metastatic or Locally Advanced Breast Cancer treatment 1 / 2 terminated NCT01131234
Gamma-Secretase Inhibitor RO4929097 and Cediranib Maleate in Treating Patients With Advanced Solid Tumors treatment 1 completed NCT01276496
Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery treatment 1 completed NCT03139435
Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer No drug interventions diagnostic Not Available completed NCT01816035
Trastuzumab Emtansine in Treating Patients With HER2-Positive Metastatic or Locally Advanced Breast Cancer That Cannot Be Removed by Surgery treatment 1 completed NCT03050463
Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer No drug interventions Not Available Not Available completed NCT01368263
Goserelin and Letrozole or Anastrozole in Premenopausal Patients With Stage II-III Estrogen Receptor-Positive Breast Cancer treatment 2 terminated NCT01928186
FLT PET in Measuring Treatment Response in Patients With Newly Diagnosed Estrogen Receptor-Positive, HER2-Negative Stage I-III Breast Cancer diagnostic Not Available completed NCT03198286
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors No drug interventions health_services_research Not Available completed NCT01417286
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer No drug interventions treatment 2 completed NCT01319539
MK2206 in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer No drug interventions treatment 2 terminated NCT02702830
MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment No drug interventions Not Available Not Available completed NCT01881048
Window of Opportunity Study Targeting the Inflammatory Milieu treatment 0 active_not_recruiting NCT03364348
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer treatment 1 completed NCT01277757
Akt Inhibitor MK2206 in Treating Patients With Advanced Breast Cancer treatment 2 completed NCT03102866
Aerobic and Strength Training Exercise in Improving Fitness and Arm Health During and After Radiation Therapy in Patients With Stage II-III Breast Cancer No drug interventions supportive_care Not Available completed NCT01158274
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors treatment 1 completed NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors treatment 1 completed NCT01750073
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer treatment 2 active_not_recruiting NCT02599194
18F-FSPG PET/CT for Cancer Patients on Therapy diagnostic 2 completed NCT02445391
Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy treatment 3 active_not_recruiting NCT01982591
Heavy Metal Exposure in Predicting Peripheral Neuropathy in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy No drug interventions Not Available Not Available completed NCT00089362
Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors treatment 1 completed NCT01385280
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer treatment Not Available completed NCT00679029
Chemotherapy & Bevacizumab for Human Epidermal Growth Factor Receptor 2 (HER2)/Neu-Negative Stage II/III Breast Cancer treatment 2 terminated NCT03039140
Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT00003440
Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic treatment 3 completed NCT01159067
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload supportive_care 2 terminated NCT00470301
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer treatment 1 / 2 completed NCT02780401
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission prevention 1 active_not_recruiting NCT01051401
Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer treatment 1 terminated NCT00060372
Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer treatment 1 completed NCT03284346
Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors No drug interventions supportive_care Not Available terminated NCT00082810
Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer treatment 2 completed NCT01493310
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer treatment 1 completed NCT02038010
BYL719 + T-DM1 in HER2(+) Metastatic Breast Cancer Pts Who Progress on Prior Trastuzumab & Taxane Tx treatment 1 completed NCT00408681
Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant supportive_care Not Available completed NCT00049114
Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer treatment 2 completed NCT02566408
Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity No drug interventions supportive_care Not Available completed NCT01776008
Akt Inhibitor MK-2206 and Anastrozole With or Without Goserelin Acetate in Treating Patients With Stage II-III Breast Cancer treatment 2 terminated NCT01868503
Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer treatment 2 terminated NCT01071564
RO4929097 and Vismodegib in Treating Patients With Breast Cancer That is Metastatic or Cannot Be Removed By Surgery treatment 1 terminated NCT01113554
Breast Cancer Rehabilitation Program in Improving Quality of Life in Breast Cancer Survivors No drug interventions treatment Not Available completed NCT01487954
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy No drug interventions supportive_care 2 completed NCT02157051
Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer No drug interventions treatment 1 active_not_recruiting NCT01222377
Endoscopic Breast Surgery in Treating Patients With Breast Cancer No drug interventions treatment Not Available terminated NCT01478477
Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole No drug interventions prevention Not Available completed NCT00572728
Phase II Study of Fluorine-18 3'-Deoxy-3'-Fluorothymidine (F-18-FLT) in Invasive Breast Cancer diagnostic 2 completed NCT01697293
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer treatment 1 / 2 terminated NCT01355393
Vaccine Therapy in Combination With Rintatolimod and/or Sargramostim in Treating Patients With Stage II-IV HER2-Positive Breast Cancer treatment 1 / 2 completed NCT01953588
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery treatment 3 active_not_recruiting NCT00407888
Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery treatment 2 completed NCT00096109
Tanespimycin in Treating Women With Refractory Locally Advanced or Metastatic Breast Cancer treatment 2 terminated NCT01149356
RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer treatment 1 terminated NCT01712815
PET/CT in Evaluating Response to Chemotherapy in Patients With Breast Cancer No drug interventions diagnostic Not Available terminated NCT02203552
Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer prevention 2 unknown_status NCT02269670
Phase II Study of Everolimus Beyond Progression treatment 2 terminated NCT00258349
Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer treatment 1 / 2 completed NCT01151449
Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced, Metastatic, or Recurrent Triple Negative Invasive Breast Cancer treatment 2 terminated NCT01243541
Cryotherapy in Preventing Peripheral Neuropathy and Nail Toxicity in Patients With Breast Cancer Who Are Receiving Paclitaxel No drug interventions supportive_care Not Available terminated NCT01483196
Vascular and Cognitive Assessments in Patients With Breast Cancer Undergoing Chemotherapy After Surgery No drug interventions diagnostic Not Available completed NCT02315196
Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer treatment 2 active_not_recruiting NCT02728596
S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) No drug interventions health_services_research Not Available completed NCT01155258
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors treatment 1 completed NCT02662335
Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT01818063
Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer treatment 2 completed NCT03025139
Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) No drug interventions supportive_care Not Available unknown_status NCT03044730
Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery treatment 2 unknown_status NCT02760030
Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery treatment 2 recruiting NCT00118157
Lapatinib and Tamoxifen in Treating Patients With Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Tamoxifen treatment 2 completed NCT00618657
Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting treatment 2 completed NCT00070057
Celecoxib in Treating Postmenopausal Women Who Are Undergoing Surgery for Invasive Breast Cancer treatment 1 completed NCT01525966
Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer treatment 2 active_not_recruiting NCT01140282
Exercise Program for Early Breast Cancer Survivors No drug interventions supportive_care Not Available completed NCT02400060
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer No drug interventions supportive_care Not Available recruiting NCT02677389
Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin No drug interventions supportive_care Not Available completed NCT02219789
Alisertib and Fulvestrant in Treating Patients With Hormone Receptor Positive Breast Cancer That is Metastatic or Locally Advanced and Cannot Be Removed by Surgery treatment 1 completed NCT01705340
Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery treatment 1 terminated NCT01194440
Zoledronic Acid in Aromatase Inhibitor Induced Musculoskeletal Symptoms supportive_care 2 completed NCT02488967
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer treatment 3 active_not_recruiting NCT00425672
ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment treatment 1 / 2 completed NCT03112668
Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners No drug interventions supportive_care Not Available completed NCT00795769
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant supportive_care 2 completed NCT00513695
Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer treatment 2 completed NCT02432950
Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer No drug interventions supportive_care Not Available completed NCT01849250
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors prevention 2 completed NCT01281150
Veliparib in Combination With Carboplatin and Paclitaxel in Treating Patients With Locally Advanced or Metastatic Solid Tumors treatment 1 completed NCT02023008
Interactive Gentle Yoga in Improving Quality of Life in Patients With Stage I-III Breast Cancer Undergoing Radiation Therapy No drug interventions supportive_care Not Available terminated NCT01755208
Light-Scattering Spectroscopy for Detection of Breast Cancer No drug interventions diagnostic Not Available terminated NCT02414646
Trastuzumab Emtansine in Treating Older Patients With Human Epidermal Growth Factor Receptor 2-Positive Stage I-III Breast Cancer treatment 2 active_not_recruiting NCT03156309
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission prevention 1 recruiting